InsuLife is a rare investment opportunity for you who want to invest with both your brain and your heart. The company has great potential for value development and at the same time aims to improve everyday life for people with diabetes - and to save lives:

• Short path to market compared to a new drug molecule
• Strong international team, board and advisory group
• Planned IPO in 2023